CONTENTS
47.
Smart packaging to improve medication adherence during clinical trials Smart bottle caps and blister packaging are transforming the clinical trials space, says Arul Joseph, senior director, pharmaceutical development and clinical supply chain, at Avanir Pharmaceuticals
51.
CMS project management in the wake of the COVID-19 pandemic Anthony Zuccarello on the benefits of efficient chemistry manufacturing and controls management in project teams
55.
Overcoming supply customs and trade compliance Q&A with Patrick Pillsbury, director, global customs, tax and trade, at Esperion, as he looks at what it takes to create an effective global trade compliance awareness campaign
59.
InTemp ‘touchless’ temperature monitoring for clinical trials T-Temp is Onset’s Bluetooth-enabled temperature monitoring system for the pharma supply chain. Onset VP Jamie Pearce highlights its benefits
62.
The global distribution of the COVID-19 vaccine via airfreight Francisco E Rizzuto explains how the airfreight industry moved mountains, and vaccines, at the height of the pandemic
68.
Next generation data logging: Cooperation of TSafe with Tec4med TSafe general manager Patrick Rivera and Nico Höler, CEO at Tec4med, discuss their cooperation on an end-to-end visibility solution that offers full temperature transparancy during the shipping process
70.
Advancing the tissue stem cell-specific fraction from semantic quality attribute to critical quality attribute for stemgene clinical trial supply Asymmetrix president and CEO James L Sherley looks at the new, innovative technologies that quantify therapeutic tissue stem cells
73.
The future of clinical supply management Analysis by Aparna Seksaria, life sciences industry solution manager, and Markus Kelbel, business transformation consultant, at SAP
77.
Unfogging the future of clinical trials: Why innovation should be a key consideration at every stage across your clinical trial supply life cycle Q&A with Luca Russo, global head, strategic science and technical operations, biotherapeutics development and supply at Janssen Research & Development
80.
Incorporating supply pooling into your clinical trial supply Q&A with Scott Sutton, senior director, supply chain, at Constellation Pharmaceuticals, on supply pooling and how it fits into your overall clinical trial supply strategy
83.
Supply chain challenges in the post-pandemic world Shell Lee, supply chain leader, takes a look at the clinical trial supply landscape and what the future holds for the sector as the world continues its recovery from the COVID-19 pandemic
86. Suppliers’ Directory Clinical Trial Supply Handbook | 5
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92
